Court order in 'Covishield' trademark lawsuit likely on Jan 30

PTI | Pune | Updated: 22-01-2021 23:56 IST | Created: 22-01-2021 23:56 IST
Court order in 'Covishield' trademark lawsuit likely on Jan 30

A Pune court hearing a suit filedby a pharmaceutical firm over the brand name 'Covishield',used by the Serum Institute of India (SII) for its COVID-19vaccine, is likely to deliver its order in the case on January30.

Cutis-Biotech had filed the suit in the civil court onJanuary 4, seeking to restrain the SII from using thetrademark Covishield or any other similar names for itsCOVID-19 vaccine and claimed the pharma firm is a prioruser of the brand name.

On Tuesday, the SII had filed its response to thelawsuit, stating that both the firms operate in differentproduct categories and there is no scope for confusion overthe trademark.

Advocate S K Jain, representing the SII, said heargued in the court on Friday that Cutis-Biotech had filedanother application before trademark registry for a vaccine inthe name of Covishield in December 2020.

''However, SII applied for the trademark in June 2020.

Thus, SII becomes the prior and first user of the trademarkCovishield,'' said Jain, adding that he also presented somematerial which showed that the work of printing the materialhaving the name of Covishield had begun in March last yearitself.

''In such a scenario, SII becomes the first user of thetrademark,'' Jain said.

Jain said the case filed by the plaintiff should bedismissed as it had cheated the court by not revealing all theinformation related to the second application of December lastyear before the trademark registry for a vaccine under thename Covishield.

Advocate Aditya Soni, representing Cutis-Biotech,countered the SII lawyer's argument about product distinction,and said it was not necessary that the products should beidentical and it was sufficient if the goods are similar, hesaid.

Soni said he had cited some judgements to counter theSII's lawyer's point that the plaintiff firm did not revealthe details about their December 2020 application.

''It is irrelevant to attach the documents (related tothe application made by Cutis-Biotech to trademark registryfor a vaccine under the name Covishield) to the present case,''Soni said.

After hearing both the sides, Additional SessionsJudge A V Rotte kept the hearing on January 30 when the orderis expected to be delivered in the case.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Addressing conflict-related sexual violence at long last

... ...

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...


Latest News

RUGBY-UNION - Penney future uncertain after Waratah's third loss

Rob Penney conceded his future as head coach of the New South Wales Waratahs could be uncertain after seeing his side lose their third straight game in Super Rugby AU on Saturday. The Waratahs slipped to a 20-16 defeat at the hands of a Wes...

Senate Democrats reach deal on jobless aid in Biden's $1.9 trillion COVID-19 bill

Democrats in the U.S. Senate said Friday they had resolved their differences over unemployment aid in President Joe Bidens 1.9 trillion COVID-19 aid bill, enabling them to move forward with the sweeping package after hours of delay. The dea...

China reports 10 new COVID-19 cases vs 9 day earlier

Mainland China reported 10 new COVID-19 cases on March 5, compared with nine cases a day earlier, the countrys national health authority said on Saturday. The National Health Commission, in a statement, said all of the new cases were import...

Fire, smoke, gunshots in Paraguay capital as pandemic response ignites protests

Protesters clashed with police in Paraguays capital, Asuncion, late on Friday as anger over the governments handling of the coronavirus crisis boiled onto the streets and forced the resignation of the countrys top health official. Security ...

Give Feedback